PLx Pharma Winddown Corp.

2018 Q3 Form 10-Q Financial Statement

#000143774918020177 Filed on November 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.54M $30.44M
YoY Change -45.66% 61.66%
Cash & Equivalents $16.54M $30.44M
Short-Term Investments
Other Short-Term Assets $560.0K $590.0K
YoY Change -5.08% 247.06%
Inventory $372.5K
Prepaid Expenses $470.5K $336.7K
Receivables $40.00K $60.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $17.14M $31.46M
YoY Change -45.51% 65.56%
LONG-TERM ASSETS
Property, Plant & Equipment $1.450M $902.4K
YoY Change 60.68%
Goodwill $2.061M $2.061M
YoY Change 0.0%
Intangibles $2.296M
YoY Change
Long-Term Investments
YoY Change
Other Assets $70.00K $60.00K
YoY Change 16.67% 0.0%
Total Long-Term Assets $3.579M $5.316M
YoY Change -32.69% 8760.75%
TOTAL ASSETS
Total Short-Term Assets $17.14M $31.46M
Total Long-Term Assets $3.579M $5.316M
Total Assets $20.72M $36.77M
YoY Change -43.66% 92.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $750.0K $1.050M
YoY Change -28.57% 3400.0%
Accrued Expenses $840.0K $2.460M
YoY Change -65.85% 186.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.952M
YoY Change
Total Short-Term Liabilities $3.541M $3.506M
YoY Change 0.99% 293.93%
LONG-TERM LIABILITIES
Long-Term Debt $5.175M $6.868M
YoY Change -24.65%
Other Long-Term Liabilities $124.4K $14.18M
YoY Change -99.12%
Total Long-Term Liabilities $5.299M $6.868M
YoY Change -22.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.541M $3.506M
Total Long-Term Liabilities $5.299M $6.868M
Total Liabilities $17.32M $24.56M
YoY Change -29.47% 2659.1%
SHAREHOLDERS EQUITY
Retained Earnings -$69.38M -$59.45M
YoY Change 16.71%
Common Stock $72.78M $71.66M
YoY Change 1.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.399M $12.22M
YoY Change
Total Liabilities & Shareholders Equity $20.72M $36.77M
YoY Change -43.66% 92.93%

Cashflow Statement

Concept 2018 Q3 2017 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
755074
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2017Q4 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
849703
CY2018Q3 plxp Contract Manufacturing Deposits Current
ContractManufacturingDepositsCurrent
86250
CY2017Q4 plxp Contract Manufacturing Deposits Current
ContractManufacturingDepositsCurrent
715603
plxp Equity Offering Proceeds Allocated To Warrant Liability
EquityOfferingProceedsAllocatedToWarrantLiability
plxp Equity Offering Proceeds Allocated To Warrant Liability
EquityOfferingProceedsAllocatedToWarrantLiability
15876546
plxp Expenses Allocated To Warrant Liability
ExpensesAllocatedToWarrantLiability
plxp Expenses Allocated To Warrant Liability
ExpensesAllocatedToWarrantLiability
1302995
plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
-94629
plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
166442
plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
173230
plxp Increase Decrease In Interest Payable To Related Parties Net
IncreaseDecreaseInInterestPayableToRelatedPartiesNet
plxp Increase Decrease In Interest Payable To Related Parties Net
IncreaseDecreaseInInterestPayableToRelatedPartiesNet
13747
plxp Increase Decrease In Research Services Deposits
IncreaseDecreaseInResearchServicesDeposits
-629353
plxp Increase Decrease In Research Services Deposits
IncreaseDecreaseInResearchServicesDeposits
247050
CY2018Q3 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
253920
CY2017Q4 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
89717
plxp Proceeds From Convertible Debt Excluding Related Parties
ProceedsFromConvertibleDebtExcludingRelatedParties
plxp Proceeds From Convertible Debt Excluding Related Parties
ProceedsFromConvertibleDebtExcludingRelatedParties
460000
plxp Proceeds From Convertible Debt Related Parties
ProceedsFromConvertibleDebtRelatedParties
588300
plxp Proceeds From Convertible Debt Related Parties
ProceedsFromConvertibleDebtRelatedParties
plxp Proceeds From Convertible Debt Related Parties
ProceedsFromConvertibleDebtRelatedParties
108300
plxp Proceeds From Issuance Of Term Loan And Warrants Net Of Allocated Issuance Costs
ProceedsFromIssuanceOfTermLoanAndWarrantsNetOfAllocatedIssuanceCosts
plxp Proceeds From Issuance Of Term Loan And Warrants Net Of Allocated Issuance Costs
ProceedsFromIssuanceOfTermLoanAndWarrantsNetOfAllocatedIssuanceCosts
7145584
plxp Proceeds From Issuance Or Sale Of Equity Net Of Allocated Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfAllocatedIssuanceCosts
plxp Proceeds From Issuance Or Sale Of Equity Net Of Allocated Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfAllocatedIssuanceCosts
16698854
plxp Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises And Forfeitures In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesAndForfeituresInPeriod
45000
plxp Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodFairValue
207537
plxp Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercises And Forfeitures In Period Weighted Average Exercise Price
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisesAndForfeituresInPeriodWeightedAverageExercisePrice
6.55
plxp Term Loan Proceeds Allocated To Warrants
TermLoanProceedsAllocatedToWarrants
plxp Term Loan Proceeds Allocated To Warrants
TermLoanProceedsAllocatedToWarrants
318398
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
750502
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
852155
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
72772537
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
71939917
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
247536
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
942040
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
765136
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1348310
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3911302
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3826302
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2017Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018Q3 us-gaap Assets
Assets
20718294
CY2017Q4 us-gaap Assets
Assets
28848573
CY2018Q3 us-gaap Assets Current
AssetsCurrent
17139589
CY2017Q4 us-gaap Assets Current
AssetsCurrent
25689962
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
15048883
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
285610
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
11776427
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24404368
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59335
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16537259
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30438464
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7867109
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
30379129
CY2018Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
16500000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8738163
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8722823
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8738163
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8722823
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
8739
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
8723
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2495630
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-920000
CY2017Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
920000
CY2018Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4064
CY2017Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4064
CY2018Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
67714
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
67714
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
145218
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12226
CY2018Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
8224992
CY2017Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
15242915
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.16
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.16
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y36D
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
600000
CY2018Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
408803
CY2017Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-252458
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7017923
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1998878
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
55405
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10064
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1800159
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3021290
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5870745
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8263019
CY2018Q3 us-gaap Goodwill
Goodwill
2061022
CY2017Q4 us-gaap Goodwill
Goodwill
2061022
CY2017Q4 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2300000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3425073
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3799500
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2049885
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8382574
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-920000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22107
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
51636
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
524245
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
255806
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-50406
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
68415
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
170356
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
249037
CY2018Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
290773
CY2017Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
168272
us-gaap Interest Expense Debt
InterestExpenseDebt
849457
us-gaap Interest Expense Debt
InterestExpenseDebt
891835
us-gaap Interest Paid Net
InterestPaidNet
497136
us-gaap Interest Paid Net
InterestPaidNet
39531
CY2018Q3 us-gaap Interest Payable Current
InterestPayableCurrent
56458
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
54219
CY2018Q3 us-gaap Inventory Net
InventoryNet
CY2017Q4 us-gaap Inventory Net
InventoryNet
246374
CY2018Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1002925
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
319736
us-gaap Inventory Write Down
InventoryWriteDown
770619
us-gaap Inventory Write Down
InventoryWriteDown
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
77276
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
33600
us-gaap Investment Income Interest
InvestmentIncomeInterest
219374
us-gaap Investment Income Interest
InvestmentIncomeInterest
48082
CY2018Q3 us-gaap Liabilities
Liabilities
17319151
CY2017Q4 us-gaap Liabilities
Liabilities
24232181
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20718294
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28848573
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3540837
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1815691
CY2018Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1952258
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
CY2018Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5175032
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6942151
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26412738
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-654870
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11577648
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7212239
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7611257
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-3425073
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-3799500
us-gaap Net Income Loss
NetIncomeLoss
-2049885
us-gaap Net Income Loss
NetIncomeLoss
-7462574
us-gaap Operating Income Loss
OperatingIncomeLoss
-8437725
us-gaap Operating Income Loss
OperatingIncomeLoss
-9537699
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
928727
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
190874
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
301993
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
349804
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-622300
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
117786
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6387840
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1155125
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
3019303
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
3979545
us-gaap Operating Expenses
OperatingExpenses
8903171
us-gaap Operating Expenses
OperatingExpenses
9975909
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2802773
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3917286
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
86056
CY2018Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
29753
CY2017Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
69516
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
86890
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
129879
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
26545
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
59614
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
124370
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
141707
us-gaap Paid In Kind Interest
PaidInKindInterest
185139
us-gaap Paid In Kind Interest
PaidInKindInterest
664865
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
654870
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
198779
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
470525
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
300169
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2346000
CY2017Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
18200000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2000000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1449969
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1029875
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
19384
CY2018Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
41491
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1219144
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
958255
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3032426
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1712890
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69382133
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67332248
CY2018Q3 us-gaap Revenues
Revenues
216530
CY2017Q3 us-gaap Revenues
Revenues
62259
us-gaap Revenues
Revenues
465446
us-gaap Revenues
Revenues
438210
us-gaap Share Based Compensation
ShareBasedCompensation
765136
us-gaap Share Based Compensation
ShareBasedCompensation
1348310
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1009459
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
85000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
90097
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
66675
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1166709
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1206709
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.54
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.93
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.46
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y292D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y292D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y73D
us-gaap Stock Issued1
StockIssued1
67500
us-gaap Stock Issued1
StockIssued1
37500
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
3399143
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
4616392
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, determining the fair value of tangible and intangible assets and liabilities acquired in business combinations, the fair value of warrant liabilities, share-based compensation, our allowance for inventory obsolescence, our allowance for doubtful accounts, contingent liabilities, the fair value and depreciable lives of long-lived assets, and deferred taxes and the associated valuation allowance. Actual results could differ from those estimates.</div></div></div>
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8735790
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8704985
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8730303
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6447053
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8735790
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8704985
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8730303
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6447053

Files In Submission

Name View Source Status
0001437749-18-020177-index-headers.html Edgar Link pending
0001437749-18-020177-index.html Edgar Link pending
0001437749-18-020177.txt Edgar Link pending
0001437749-18-020177-xbrl.zip Edgar Link pending
ex_126584.htm Edgar Link pending
ex_126585.htm Edgar Link pending
ex_126586.htm Edgar Link pending
ex_127181.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
plxp-20180930.xml Edgar Link completed
plxp-20180930.xsd Edgar Link pending
plxp-20180930_cal.xml Edgar Link unprocessable
plxp-20180930_def.xml Edgar Link unprocessable
plxp-20180930_lab.xml Edgar Link unprocessable
plxp-20180930_pre.xml Edgar Link unprocessable
plxp20180930_10q.htm Edgar Link pending
plxp20180930_10qimg001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending